Royalty Pharma plc - Class A ordinary shares, par value $0.0001 per share (RPRX)

CUSIP: G7709Q104

Q2 2024 13F Holders as of 30 Jun 2024

Holder snapshot 7 signals
Share change
+5,297,167
Put/Call ratio
46%
SEC-reported price per share
$26.37
Number of holders
373
Value change
+$126,311,822
Number of buys
192
Open additional details 1 more signal available
Number of sells
182
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
543,437,496

Security key

G7709Q104

Report period

Q2 2024

Institutions

373

Top holders

10

Ownership snapshot

Top reported holders of RPRX - Royalty Pharma plc - Class A ordinary shares, par value $0.0001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
GG 1978 SICAF SIF S.A.
Disclosed value leader
MORGAN STANLEY
Comparable rows
0/15
Latest evidence
31 Mar 2024
3/4/5 13F Highest disclosed value: $1,342,897,348 15 rows are not safely comparable across share classes. Showing 1-6 of 15 holder rows.

Quick read

MORGAN STANLEY has the largest disclosed position value at $1.34B.

0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens MORGAN STANLEY's linked filing trail.
Disclosed position value Top 5
GG 1978 SICAF SIF S.A. $608.28M
GG 1978 SICAF SIF S.A. - GG Strat... $590.24M
Mario Germano Giuliani $96.01M
Avara Management Ltd $68.46M
MORGAN STANLEY $1.34B

Value bars compare disclosed positions; verify each figure against the linked filing evidence.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
GG 1978 SICAF SIF S.A.
3/4/5
10%+ Owner
—
denominator unverified
$608,282,853
22,081,156 shares
— 14 Sep 2022
GG 1978 SICAF SIF S.A. - GG Strategic
3/4/5
10%+ Owner
—
denominator unverified
$590,239,561
21,426,170 shares
— 20 Sep 2022
Mario Germano Giuliani
3/4/5
Director, 10%+ Owner
—
denominator unverified
$96,010,741
3,485,267 shares
— 23 Jun 2023
Avara Management Ltd
3/4/5
10%+ Owner
—
denominator unverified
$68,463,141
2,485,267 shares
— 29 Dec 2023
MORGAN STANLEY
13F
Company
13F
—
denominator unverified
$1,342,897,348
44,217,888 shares
— 31 Mar 2024
VANGUARD GROUP INC
13F
Company
13F
—
denominator unverified
$1,144,939,343
37,699,682 shares
— 31 Mar 2024
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q2 2024

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
373
Shares
316,171,106
Rows available
373
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q2 2024 vs Q1 2024 Across Filers

Q1 2024 holders
375
Q2 2024 holders
373
Holder diff
-2
Investor Q1 2024 Shares Q2 2024 Shares Share Diff Share Chg % Q1 2024 value Q2 2024 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .